Fabio Perini Acquires Remaining 30 percent Share in Engraving Solutions from Simec
Print this Article | Send to Colleague
Fabio Perini and NARA (Simec Group) have completed the transfer of all the investments in Engraving Solutions to Fabio Perini which already held 70 percent of the company's shares.
The consolidated industrial partnership between the two groups will remain active in the future for a better customer satisfaction and will continue to innovate following the needs of the market.
Engraving Solutions was founded in 2003 thanks to the union of intentions of Fabio Perini and Simec Group, a leader in the production of rolls with surface machining for different application sectors. Thanks to the know-how and technological excellence of the two companies, it immediately distinguished itself in the market for its ability to develop new designs and to support the customer in the study of engravings for embossed products in the Tissue sector.
More than 4,000 rolls already produced, the creation of over 12,000 embossing graphics solutions and 15 patents active all over the world, are the assets of Engraving Solutions. Currently, 20 employees work at the Lucca plant. Among the most successful products at the international level, we mention the Softop, PP-Evo, 4D, and Pixel.
"This acquisition is in line with our growth strategy 2025 and strengthens our positioning on the Tissue Area business market," Oswaldo Cruz, CEO of Fabio Perini, explained. "Engraving Solutions is an important and strategic resource for our tissue companies that will benefit from this consolidated experience and will be able to provide increasingly customized and innovative solutions to maximize the added value of our customers' finished products ".
"This experience," stated Laura Della Torre, member of the board of Simec Group, "has made possible the exchange of knowledge between the parties involved and has enriched the background and the specific know-how of the sector. Simec Group has also been able to focus on other segments, strengthening its production assets and nowadays it is a leading company thanks to the wide range of applications available in its product portfolio".
Fabio Perini with its five production sites in Italy, the US, Brazil and China, claims to be the only company, on a global scale, capable of producing complete lines of tissue production, integrating converting and packaging, offering exceptional advantages in controlling the entire production process, optimizing performance, maximizing the quality of the finished product and reducing operating costs.
The new way of interpreting Industry 4.0 has led Fabio Perini S.p.A. to define new solutions to manage the machines, lines, and production, processes, and activities that set the world of Digital Tissue™. All this helps to have intelligent structures that allow maximizing the production efficiency of the individual machines, the complete lines and even more the effectiveness of the production sites.
Back to Tissue360 Newsletter |